Pregnancy-induced changes in breast cancer risk

Journal of Mammary Gland Biology and Neoplasia

Volumn 16, Issue 3, 2011, Pages 221-233

  Russo, Irma H ^a   Russo, Jose ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer prevention; Breast cancer risk; Early pregnancy; Human chorionic gonadotropin; Hypothalamic aging; Hypothalamic pituitarygonadal axis; Late pregnancy

Indexed keywords

3 METHYLCHOLANTHRENE; BENZO[A]PYRENE; BIOLOGICAL MARKER; CARCINOGEN; CHORIONIC GONADOTROPIN; DIMETHYLBENZ[A]ANTHRACENE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MESTRANOL PLUS NORETYNODREL; METHYLNITROSOUREA; MOLECULAR MARKER; POLYCYCLIC AROMATIC COMPOUND; PROGESTERONE; PROTEIN P53; TAMOXIFEN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER PREVENTION; CANCER RISK; CANCER STEM CELL; DNA REPAIR; DOSE RESPONSE; FEMALE; FEMALE FERTILITY; FIRST TRIMESTER PREGNANCY; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LACTATION; MAMMARY GLAND; NEUROENDOCRINE SYSTEM; NONHUMAN; OVARIECTOMY; PARITY; PREGNANCY; PRIMIGRAVIDA;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; PREGNANCY; RISK FACTORS;

EID: 80053569605     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-011-9228-y     Document Type: Article

References (104)

1. Breasted JH, editor. The Edwin Smith Surgical Papyrus: published in facsimile and hieroglyphic transliteration with translation and commentary in two volumes, vol. 1. Chicago: University of Chicago Press; 1991.
2. Clarke CA, Purdie DM, Glaser SL. Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. BMC Cancer. 2006;6:170.
3. Botha JL, Bray F, Sanlika R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Europ J Cancer. 2003;39:1718-29. (Pubitemid 36897609)
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
5. Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, et al. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol. 2006;36:387-94. (Pubitemid 44043929)
6. Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT. Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat. 2007;104:47-56. (Pubitemid 46976628)
7. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol. 2005;34:405-12. (Pubitemid 40645331)
8. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, et al. Age at first birth and breast cancer risk. Bull World Health Organ. 1970;43:209-21.
9. Hinkula M, Pukkala E, Kyyrönen P, Kauppila A. Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control. 2001;12:491-500. (Pubitemid 32735121)
10. Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, et al. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res. 2010;12:R35.
11. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst. 2011;103:1-8.
12. Toniolo P, Grankvist K, Wulff M, Chen T, Johansson R, Schock H, et al. Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer. Cancer Res. 2010;70:6779-86.
13. Mustacchi P. Ramazzini and Rigoni-Stern on parity and breast cancer. Clinical impression and statistical corroboration. Arch Intern Med. 1961;108:639-42.
14. Kroman N, Mouridsen HT. Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast. 2003;12:516-21. (Pubitemid 38008667)
15. Kroman N, Melbye M, Mouridsen HT. Prognostic influence of age at diagnosis in premenopausal breast cancer patients. Scand J Surg. 2002;91:305-8. (Pubitemid 35285310)
16. Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008;100:1643-8.
17. Downs JL, Wise PM. The role of the brain in female reproductive aging. Mol Cell Endocrinol. 2009;299:32-8.
18. Russo IH, Medado J, Russo J. Endocrine influences on mammary gland structure and development. In: Jones TC, Mohr U, Hunt RD, editors. Integument and mammary gland of laboratory animals. Berlin: Springer Verlag; 1989. p. 252-66.
19. Chen T, Lundin E, Grankvist K, Zeleniuch-Jacquotte A, Wulff M, Afanasyeva Y, et al. Maternal hormones during early pregnancy: a cross-sectional study. Cancer Causes Control. 2010;21:719-27.
20. Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment with illustrative cases. Lancet. 1896;2:104.
21. Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. Steroid Biochem Mol Biol. 2006;102:89-96. (Pubitemid 44750629)
22. Russo J, Russo IH, editors. Molecular basis of breast cancer: prevention and treatment. Berlin: Springer Verlag; 2004.
23. Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, et al. Circulating estrogens and progesterone during primiparous. pregnancies and risk of maternal breast cancer. Int J Cancer 2011; March16:000:000-000.
24. Albrektsen G, Heuch I, Thoresen S, Kvale G. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol Biomarkers Prev. 2006;15:65-9.
25. Russo IH, Koszalka M, Gimotty PA, Russo J. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer. 1990;62:243-7. (Pubitemid 20242443)
26. Russo IH, Koszalka M, Russo J. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer. 1991;64:481-4.
27. Russo J, Russo IH. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol. 1980;100:497-512. (Pubitemid 10037090)
28. Russo J, Tay LK, Ciocca D, Russo IH. Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis. Environ Health Perspect. 1983;49:185-99. (Pubitemid 13098355)
29. Welsch CW. Host factors affecting the growth of carcinogeninduced rat mammary carcinomas: A review and tribute to Charles Brenton Huggins. Cancer Res. 1985;45:3415-43. (Pubitemid 15226403)
30. Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996;104:938-67. (Pubitemid 26372400)
31. McCormick GM, Moon RC. Effect of nursing and litter size on growth of 7, 12-dimethylbenz (a) anthracene (DMBA)-induced rat mammary tumors. Br J Cancer. 1967;21:586-91.
32. Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G, et al. Prepubertal estradiol and genistein exposures upregulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis. 2004;25:741-8. (Pubitemid 38618526)
33. Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, et al. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res. 2006;66:6421-31.
34. Lakshmanaswamy R, Guzman RC, Nandi S. Hormonal prevention of breast cancer: significance of promotional environment. Adv Exp Med Biol. 2008;617:469-75.
35. Medina D, Smith GH. Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands. J Natl Cancer Inst. 1999;91:967-69. (Pubitemid 29272524)
36. Medina D, Kittrell FS. p53 function is required for hormonemediated protection of mouse mammary tumorigenesis. Cancer Res. 2003;63:6140-3. (Pubitemid 37255152)
37. Medina D. Chemical carcinogenesis of rat and mouse mammary glands. Breast Dis. 2007;28:63-8. (Pubitemid 350187026)
38. Medina D. Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens. J Mammary Gland Biol Neoplasia. 2008;13:271-7.
39. Shen Q, Brown PH. Transgenic mouse models for the prevention of breast cancer. Mutat Res. 2005;576:93-110. (Pubitemid 40982685)
40. Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D. Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res. 2007;9:R12.
41. Allred DC, Medina D. The relevance of mouse models to understanding the development and progression of human breast cancer. J Mammary Gland Biol Neoplasia. 2008;13:279-88.
42. Borowsky AD. Choosing a mouse model: Experimental biology in context-The utility and limitations of mouse models of breast cancer. Cold Spring Harb Perspect Biol 2011.
43. Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P. Tamoxifen inhibition of estrogen receptor-alphanegative mouse mammary tumorigenesis. Cancer Res. 2005;65:3493-6. (Pubitemid 40524637)
44. Rao GN, Piegorsch WW, Haseman JK. Influence of body weight on the incidence of spontaneous tumors in rats and mice of long term studies. Am J Clin Nutr. 1987;45:252-60.
45. Tarone RE, Chu KC, Ward JM. Variability in the rates of some common naturally occurring tumors in Fischer 344 rats and (C57BLU6N x C3/HeN) F1 (B6C3F,) mice. J Natl Cancer Inst. 1981;66:1175-81. (Pubitemid 11063918)
46. Huggins C, Briziarelli G, Sutton H. Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med. 1959;709:25-42.
47. Huggins C, Grand L, Fukunishi R. Aromatic influences in the yields of mammary cancers following administration of 7, 12-dimethylbenzanthracene. Proc Natl Acad Sci USA. 1964;57:737-42.
48. Gullino PM, Pettigrew HM, Grantham FH. N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst. 1975;54:401-14.
49. Thordarson G, Lee AV, McCarty M, Van Horn K, Chu O, Chou YC, et al. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Carcinogenesis. 2001;22:2039-47. (Pubitemid 34065401)
50. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, Van Zwieten MJ. Comparative study of human and rat mammary tumorigenesis. Lab Invest. 1990;62:1-32.
51. Moral R, Wang R, Russo IH, Lamartiniere CA, Pereira J, Russo J. Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol 2008;196:101-12. (Pubitemid 351234575)
52. Kawaguchi H, Miyoshi N, Miyamoto Y, Souda M, Umekita Y, Yasuda N, et al. Effects of fetal exposure to diethylstilbestrol on mammary tumorigenesis in rats. Vet Med Sci. 2009;71:1599-608.
53. Umekita Y, Souda M, Hatanaka K, Hamada T, Yoshioka T, Kawaguchi H, et al. Gene expression profile of terminal end buds in rat mammary glands exposed to diethylstilbestrol in neonatal period. Toxicol Lett 2011;205:15-25.
54. Goodman A, Schorge J, Greene MF. The long-term effects of in utero exposures-the DES story. N Engl J Med. 2011;364:2083-4.
55. Russo IH, Russo J. Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res. 2007;174:111-30.
56. Russo J, Tait L, Russo IH. Susceptibility of the mammary gland to carcinogenesis: III the cell of origin of rat mammary carcinoma. Am J Path. 1983;113:50-66. (Pubitemid 13009968)
57. Russo J, Balogh GA, Chen J, Fernandez SV, Fernbaugh R, Heulings R, et al. The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci. 2006;11:151-72. (Pubitemid 43253483)
58. Bennett DC, Peachey LA, Durbin H, Rudland PS. A possible mammary stem cell line. Cell. 1978;15:283-98. (Pubitemid 9027532)
59. Bussard KM, Smith GH. The mammary gland microenvironment directs progenitor cell fate in vivo. Int J Cell Biol. 2011;2011:451676.
60. Navarro VM, Castellano JM, Fernandez-Fernandez R, Barreiro ML, Roa J, Sanchez-Criado JE, et al. Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor GPR54 in rat hypothalamus and potent LH releasing activity of KiSS-1 peptide. Endocrinology. 2004;145:4565-74. (Pubitemid 39281449)
61. Kinoshita M, Tsukamura H, Adachi S, Matsui H, Uenoyama Y, Iwata K, et al. Involvement of central metastin in the regulation of preovulatory luteinizing hormone surge and estrous cyclicity in female rats. Endocrinology. 2005;146:4431-6. (Pubitemid 41324041)
62. Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression. J Mam Gland Biology Neoplasia. 1998;3:49-61. (Pubitemid 128513219)
63. Russo IH, Frederick J, Russo J. Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol. Breast Cancer Res Treat. 1989;14:43-56. (Pubitemid 20023423)
64. Vanegas JE, Kocdor M, Pereira JS, Kocdor H, Russo J, Snider K, et al. Mammary cancer prevention by short treatment with human chorionic gonadotropin. Proc Am Assoc Cancer Res. 2009;100:2059a.
65. Srivastava P, Russo J, Russo IH. Chorionic gonadotropin inhibits mammary carcinogenesis through activation of programmed cell death. Carcinogenesis. 1997;18:1799-808. (Pubitemid 28134688)
66. Srivastava P, Russo J, Russo IH. Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin is associated with increased expression of inhibin. Mol Carcinog. 1999;26:10-9. (Pubitemid 29420181)
67. Russo IH, Russo J. Chorionic gonadotropin: a tumoristatic and preventive agent in breast cancer. In: Teicher BA, editor. Drug resistance in oncology. New York: Dekker; 1993. p. 537-60.
68. McCormick GM, Moon RC. Effect of pregnancy and lactation on growth of mammary tumours induced by 7, 12-dimethylbenzanthracene (DMBA). Br J Cancer. 1965;79:160-6.
69. Dao TL, Sunderland H. Mammary carcinogenesis by 3-methylcholanthrene. I. Hormonal aspects in tumor induction and growth. J Natl Cancer Inst. 1959;23:567-85.
70. Grubbs CJ, Hill DL, McDonough KC, Peckham JC. N-Nitroso-N-methylurea- induced mammary carcinogenesis: effect of pregnancy on preneoplastic cells. J Natl Cancer Inst. 1983;71:625-8. (Pubitemid 13012143)
71. Jordan VC. Effect of tamoxifen (ICI 46, 474) on the initiation and growth of DMBA-induced rat mammary carcinoma. Eur J Cancer. 1976;12:419-24.
72. Weroha SJ, Li SA, Tawfik O, Li JJ. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis. 2006;27:491-8. (Pubitemid 43372878)
73. Li SA, Weroha SJ, Tawfik O, Li JJ. Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J Endocrinol. 2002;175:297-305. (Pubitemid 35422606)
74. Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, et al. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J. 2006;20:1622-34. (Pubitemid 44943799)
75. Russo IH, Gimotty P, Dupuis M, Russo J. Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis. Br J Cancer. 1989;59:210-6. (Pubitemid 19072719)
76. Lanari C, Lamb CA, Fabris VT, Helguero LA, Soldati R, Bottino MC, et al. The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer. 2009;16:333-50.
77. Russo J, Balogh GA, Heulings R, Mailo DA, Moral R, Russo PA, et al. Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev. 2006;15:306-42. (Pubitemid 44060488)
78. Wagner KU, Boulanger CA, Henry MD, Sgagias M, Hennighausen L, Smith GH. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development. 2002;129:1377-86. (Pubitemid 34874159)
79. Boulanger CA, Wagner KU, Smith GH. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta 1 expression. Oncogene. 2005;24:552-60. (Pubitemid 40188560)
80. Booth BW, Boulanger CA, Smith GH. Selective segregation of DNA strands persists in long-label-retaining mammary cells during pregnancy. Breast Cancer Res. 2008;10:R90.
81. Blackshaw S, Scholpp S, Placzek M, Ingraham H, Simerly R, Shimogori T. Molecular pathways controlling development of thalamus and hypothalamus: from neural specification to circuit formation. J Neurosci. 2010;30:14925-30.
82. Hendriks AE, Lavens JS, Valkenburg O, Fong SL, Fauser BC, de Ridder MA, et al. Fertility and ovarian function in high-dose estrogen-treated tall women. J Clin Endocrinol Metab. 2011;96:1098-105.
83. Russo J, Russo IH. Development of human mammary gland. In: Neville MC, Daniel C, editors. The mammary gland development, regulation and function. New York: Plenum; 1987. p. 67-93.
84. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat. 1992;23:211-8.
85. Howell A, Evans GD. Hormone replacement therapy and breast cancer. Recent Results Cancer Res. 2011;188:115-24.
86. Lathi RB, Fisher SJ, Giudice LC. Implantation and placental physiology in early human pregnancy: the role of the maternal decidua and the trophoblast. In: De Groot L, Jameson LJ, editors. Endocrinology. Philadelphia: Elsevier; 2006. p. 3341-51.
87. Parry S, Strauss III F. Placental hormones. In: De Groot L, Jameson LJ, editors. Endocrinology. Philadelphia: Elsevier; 2006. p. 3353-67.
88. Alvarado MV, Ho T-Y, Russo J, Russo IH. Human chorionic gonadotropin regulates the synthesis of inhibin in the ovary and the mammary gland of rats. Endocrine. 1994;2:1-10.
89. Alvarado ME, Alvarado NE, Russo J, Russo IH. Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro. In Vitro. 1994;30A:4-8. (Pubitemid 24166999)
90. Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S, et al. Dramatic Elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 2003;88:914-9. (Pubitemid 36207842)
91. McGregor, Land CE, Choi K, Tokuoka S, Liu PI, Wakabayashi I, et al. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagaski 1950-1989. J Natl Cancer Inst. 1977;59:799-811. (Pubitemid 8177492)
92. Cutuli B, Borel C, Dhermain F, Magrini SM, Wasserman TH, Bogart JA, et al. Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. Radiother Oncol. 2001;59:247-55. (Pubitemid 32429572)
93. Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG, et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian expert panel on tobacco smoke and breast cancer risk (2009). Tob Control. 2011;20:e2.
94. Johansson AL, Andersson TM, Hsieh CC, Cnattingius S, Lambe M. Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev. 2011.
95. Hahn RA, Moolgavkar SH. Nulliparity, decade of first birth, and breast cancer in Connecticut cohorts, 1855 to 1945: an ecological study. Am J Public Health. 1989;79:1503-7. (Pubitemid 19270294)
96. Mathews TJ, Hamilton BE. Delayed childbearing: more women are having their first child later in life. NCHS data brief, No. 21. Hyattaville: National Center for Health Statistics; 2009.
97. Balogh GA, Heulings R, Mailo DA, Russo PA, Sheriff F, Russo IH, et al. Genomic signature induced by pregnancy in the human breast. Int J Oncol. 2006;28:399-410.
98. Russo J, Balogh GA, Russo IH. Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol. Biomarkers Prev. 2008;17:51-66. (Pubitemid 351196273)
99. George K, Kamath MS. Fertility and age. J Hum Reprod Sci. 2010;3:121-3.
100. Homan GF, Davies M, Norman R. The impact of lifestyles factors on reproductive performance in the general population and those undergoing infertility treatment. Hum Reprod Update. 2007;13:209-23. (Pubitemid 47061631)
101. Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol. 2011;9:23.
102. Wise PM, Smith MJ, Dubal DB, Wilson ME, Rau SW, Cashion AB, et al. Neuroendocrine modulation and repercussions of female reproductive aging. Recent Prog Horm Res. 2002;57:235-56.
103. Danforth DR, Arbogast LK, Mroueh J, Kim MH, Kennard EA, Seifer DB, et al. Dimeric inhibin: a direct marker of ovarian ageing. Fertil Steril. 1998;70:119-23. (Pubitemid 28294633)
104. Rance NE. Menopause and the human hypothalamus: evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback. Peptides. 2009;30:111-22.